CRDL – cardiol therapeutics inc. - class a common shares (US:NASDAQ)
Stock Stats
News
Cardiol Therapeutics Inc. (NASDAQ: CRDL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Cardiol Therapeutics Inc. (NASDAQ: CRDL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $9.00 price target on the stock.
Cardiol Therapeutics Inc. (NASDAQ: CRDL) was upgraded by analysts at RODMAN&RENSHAW to a "strong-buy" rating.
Cardiol Therapeutics Inc. (NASDAQ: CRDL) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $7.00 price target on the stock.
Form 6-K Cardiol Therapeutics For: Apr 01
Form 40-F Cardiol Therapeutics For: Dec 31
Form 6-K Cardiol Therapeutics For: Mar 14
Form 6-K Cardiol Therapeutics For: Mar 03
Form 6-K Cardiol Therapeutics For: Feb 20
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.